All Articles

Hisense's dazzling World Cup pop-up at Hudson Yards offers fans a tech-fueled fantasy. But beneath the surface lies a calculated play for market dominance.

As SpaceX makes its historic market debut, GraniteShares launches leveraged ETFs, offering traders a high-stakes way to bet on the volatile space pioneer.

A new survey shows Asians value independence over inheritance, yet a massive gap between intention and action threatens to derail their plans for self-reliance.

Elixiron's enrupatinib shows promise in targeting neuroinflammation, with early data suggesting cognitive benefits and a new biomarker-guided path for therapy.

The recent acquisition of a thriving San Diego shopping center is more than a real estate deal. It's a test case for an ambitious plan to remake suburbia.

As Singapore's non-bank lending space heats up, Bizcap unveils a lucrative loyalty program. Is this a game-changer for SME funding or just a costly gambit?

Industrial giants struggle to scale automation beyond pilot projects. A new CEO playbook from ASI, backed by millions of autonomous miles, offers a blueprint.

As Ottawa rolls out a new food strategy, Pamela Cox examines whether it can fix a broken system of soaring costs and deep-seated insecurity for millions.

For decades, patients with a rare autoimmune anemia faced a cycle of steroids and relapse. New data on a targeted therapy may finally offer a durable solution.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

As FIFA World Cup 2026 kicks off, Hisense is executing a masterclass in market disruption, using the global stage to redefine the TV landscape with RGB MiniLED.

A Korean materials firm just won a top Boeing award. We go beyond the press release to reveal how it’s fortifying global supply chains and reshaping Asia's aerospace hub.

A new financing vehicle aims to de-risk high-integrity carbon projects, but can this "carbon streaming" model unlock Central Asia's climate potential?

FCPT's latest acquisition seems minor, but it reveals a powerful strategy for navigating economic uncertainty by targeting essential, service-based real estate.

As hospitals face a ballooning $55B annual IT bill, Vizient's latest acquisition signals a major offensive to control costs beyond the traditional supply chain.

After a decade-long hiatus from major global partnerships and a recent financial overhaul, Oriflame is betting on spectacle. But is this a savvy brand revival or a costly distraction?

JAB's ~$1.8B sale of its final KDP stake isn't just an exit; it's a masterclass in capital reallocation towards a focused consumer brand empire.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

Northfield shareholders face a July 10 deadline to pick cash or stock in a merger tied to a complex bank conversion set to reshape the NJ/NY banking landscape.

Amid market uncertainty, Vornado's $1.1B valuation deal for Park Avenue Plaza signals a bullish long-term view on New York City's trophy office space.